Defining the risk of adverse cardiovascular events for patients undergoing anti-VEGF treatment for neovascular AMD

被引：0
|
作者：
Chong, David Donghan [1 ]
Maatouk, Christopher M. [1 ,2 ]
Singh, Rishi [3 ]
Talcott, Katherine [2 ]
机构：
[1] Case Western Reserve Univ, Sch Med, Cleveland, OH USA
[2] Cleveland Clin, Cole Eye Inst, Cleveland, OH USA
[3] Cleveland Clin Martin Hlth, Stuart, FL USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2023年 / 64卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
2230
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Defining response to anti-VEGF therapies in neovascular AMD
    W M Amoaku
    U Chakravarthy
    R Gale
    M Gavin
    F Ghanchi
    J Gibson
    S Harding
    R L Johnston
    S Kelly
    A Lotery
    S Mahmood
    G Menon
    S Sivaprasad
    J Talks
    A Tufail
    Y Yang
    [J]. Eye, 2015, 29 : 721 - 731
  • [2] Defining response to anti-VEGF therapies in neovascular AMD
    Amoaku, W. M.
    Chakravarthy, U.
    Gale, R.
    Gavin, M.
    Ghanchi, F.
    Gibson, J.
    Harding, S.
    Johnston, R. L.
    Kelly, S.
    Lotery, A.
    Mahmood, S.
    Menon, G.
    Sivaprasad, S.
    Talks, J.
    Tufail, A.
    Yang, Y.
    [J]. EYE, 2015, 29 (06) : 721 - 731
  • [3] Driving vision in patients with neovascular AMD in anti-VEGF treatment
    Herlov Baselius, Nanna Jo
    Brynskov, Troels
    Falk, Mads Kruger
    Sorensen, Torben Lykke
    Subhi, Yousif
    [J]. ACTA OPHTHALMOLOGICA, 2021, 99 (08) : E1360 - E1365
  • [4] Erratum: Defining response to anti-VEGF therapies in neovascular AMD
    W M Amoaku
    U Chakravarthy
    R Gale
    M Gavin
    F Ghanchi
    J Gibson
    S Harding
    R L Johnston
    S P Kelly
    A Lotery
    S Mahmood
    G Menon
    S Sivaprasad
    J Talks
    A Tufail
    Y Yang
    [J]. Eye, 2015, 29 : 1397 - 1398
  • [5] High-Frequency Anti-VEGF Treatment for Neovascular AMD
    Matthews, Dillion
    Kapoor, Kapil G.
    Wagner, Alan
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [6] Intravitreal anti-VEGF therapy with bevacizumab for neovascular AMD
    Schaal, K. B.
    Engler, C.
    Schuett, F.
    Scheuerle, A.
    Dithmar, S.
    [J]. OPHTHALMOLOGE, 2008, 105 (06): : 538 - +
  • [7] Defining response to anti-VEGF therapies in neovascular AMD (vol 29, pg 721, 2015)
    Amoaku, W. M.
    Chakravarthy, U.
    Gale, R.
    Gavin, M.
    Ghanchi, F.
    Gibson, J.
    Harding, S.
    Johnston, R. L.
    Kelly, S. P.
    Lotery, A.
    Mahmood, S.
    Menon, G.
    Sivaprasad, S.
    Talks, J.
    Tufail, A.
    Yang, Y.
    [J]. EYE, 2015, 29 (10) : 1397 - 1398
  • [8] Anti-VEGF resistance in neovascular AMD: Role of PDGF antagonism
    Dugel, Pravin U.
    Kunimoto, Derek
    Quinlan, Edward
    Jamal, Karim
    Goldenberg, David
    Mehta, Sachin
    Witmer, Matthew
    Barakat, Mark
    Hakimbashi, Milad
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [9] Phacoemulsification in eyes with neovascular AMD treated with anti-VEGF injections
    Muzyka-Wozniak, Maria
    [J]. EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2011, 21 (06) : 766 - 770
  • [10] Epidemiological and Clinical Baseline Characteristics as Predictive Biomarkers of Response to Anti-VEGF Treatment in Patients with Neovascular AMD
    Tsilimbaris, Miltiadis K.
    Lopez-Galvez, Maria I.
    Gallego-Pinazo, Roberto
    Margaron, Philippe
    Lambrou, George N.
    [J]. JOURNAL OF OPHTHALMOLOGY, 2016, 2016
12345